Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-176099
Filing Date
2015-05-07
Accepted
2015-05-07 09:00:54
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d899443d10q.htm 10-Q 180394
2 EX-31.1 d899443dex311.htm EX-31.1 8696
3 EX-31.2 d899443dex312.htm EX-31.2 8478
4 EX-32.1 d899443dex321.htm EX-32.1 4636
  Complete submission text file 0001193125-15-176099.txt   2056080

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT meip-20150331.xml EX-101.INS 186744
6 XBRL TAXONOMY EXTENSION SCHEMA meip-20150331.xsd EX-101.SCH 21896
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20150331_cal.xml EX-101.CAL 25079
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20150331_def.xml EX-101.DEF 143121
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20150331_lab.xml EX-101.LAB 219996
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20150331_pre.xml EX-101.PRE 164122
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 15839664
SIC: 2834 Pharmaceutical Preparations